L-carnitine in inborn errors of metabolism: what is the evidence
Prevention remains the most effective strategy against STD-related throat infections
A recent press release reported topline results indicating that tirzepatide met the primary objective of noninferiority compared with dulaglutide for time to first occurrence of death from cardiovascular causes, nonfatal myocardial infarction or nonfatal stroke (HR 0.92, 95.3% CI 0.831.01), along with a reduction in all-cause mortality (HR 0.84, 95% CI 0.750.94)
However, scientists are still exploring all the ways it might be useful
Krajewska M, Kitada S, Winter JN, Variakojis D, Lichtenstein A, Zhai D, Cuddy M, Huang X, Luciano F, Baker CH, Kim H, Shin E, Kennedy S, Olson AH, Badzio A, Jassem J, Meinhold-Heerlein I, Duffy MJ, Schimmer AD, Tsao M, Brown E, Sawyers A, Andreeff M , Mercola D, Krajewski S, Reed JC